MAK and ciliopathy: Understanding how CILK1 and MAK regulate the IFT turnaround process by phosphorylating the downstream target(s) could reveal the extent to which the activation of CCRK-CILK1/MAK kinase signaling can be more generally applicable to treat human ciliopathies.